Madelung's disease: long-term follow-up

Area of Science:

• Endocrinology
• Metabolic Disorders
• Surgical Pathology

Background:

• Madelung's disease (MD) is a rare, benign lipodystrophy characterized by excessive adipose tissue accumulation, often linked to alcohol abuse.
• While MD itself is not fatal, associated alcoholism and metabolic derangements pose significant life-threatening risks.
• Long-term follow-up data for MD patients, particularly regarding management and outcomes, remain scarce in medical literature.

Observation:

• This report details a 12-year follow-up of a 61-year-old Japanese male diagnosed with Madelung's disease.
• The patient underwent three lipectomies within the initial three years, with approximately 4 kg of adipose tissue removed, and experienced no relapse.
• During the follow-up period, the patient developed multiple hepatocellular carcinomas (MHC) and required dialysis for hepatorenal syndrome secondary to alcoholism. A ruptured MHC led to hemorrhagic shock.

Findings:

• Surgical intervention for MD, such as lipectomy, can effectively manage adipose tissue overgrowth without recurrence.
• The primary cause of mortality in patients with Madelung's disease is not the lipodystrophy itself but rather its severe comorbidities, including advanced liver disease and its complications.
• Alcoholism-induced complications, such as multiple hepatocellular carcinomas and hepatorenal syndrome, represent critical health threats in MD patients.

Implications:

• Long-term, multidisciplinary management is crucial for patients with Madelung's disease to address and mitigate life-threatening comorbidities.
• Effective management strategies should focus on controlling alcohol consumption and monitoring for associated metabolic and oncological complications.
• Further research into the long-term prognosis and optimal systemic management of Madelung's disease is warranted to improve patient outcomes.